AHA Center for Health Innovation Market Scan

AHA Center for Health Innovation’s Market Scan articles provide insights and analysis on the field’s latest developments in health care disruption, transformation and innovation.

Read the latest newsletters and subscribe to Market Scan.

Follow us to learn more.

The recent CES 2024 show (formerly the Consumer Electronics Show) produced a number of health care-related, attention-getting devices. Some are not commercially available yet, but these products have the potential to help patients take greater control of their health.
Health care executives from hospitals and health systems, retail health providers and investors came together recently to share insights and outlooks at the 2024 J.P. Morgan Healthcare Conference. Several retail health companies offered insights into their latest moves and plans.
In a recently released Executive Insights report, “Rising Demand for Surgeries and Advancing the Quintuple Aim Through Innovation,” from the AHA Center for Health Innovation, clinical leaders across the country share their insights on how to integrate artificial intelligence (AI) and other…
As health care continues to transform in 2024, executives will face challenges related to finances, technology, workforce and other areas. Across the field, thought leaders have been busy offering their best guesses, insights and predictions for how this year is likely to shake out.
To grow and retain their workforce, hospitals and health systems need to pursue a multipronged approach, notes the AHA’s recently released 2024 Health Care Workforce Scan.
Ballad Health in Johnson City, Tennessee, recently completed an interesting pilot to improve communication around medication adherence. It worked with Grapefruit Health, a startup focused on addressing health care’s staffing shortage by creating a workforce solely comprising clinical students.
The recently released AHA 2024 Environmental Scan offers a wealth of data and context on these challenges to assist health care leaders in their strategic planning as they reshape the future of health care.
CVS Health plans to launch its CVS CostVantage and CVS Caremark TrueCost programs in 2025. CostVantage will define the drug cost and related reimbursement with contracted PBMs and payers, CVS noted in a statement.
A new AHA Center for Health Innovation report, “Leveling the Playing Field in Health Equity Investing,” explores the challenges these entrepreneurs face, how some venture capital (VC) funds are expanding opportunities for underrepresented startups and how the field can benefit.
To truly engage patients in shared decision-making and provide proper informed consent, clinicians not only need the appropriate risk data, but they need to share it with patients and document these conversations.